By Drug Target Review2025-04-28T08:30:07
Scientists have developed lab-grown liver organoids with functional zonation, a discovery that brings regenerative medicine a step closer to personalised, transplant-free liver therapy.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-26T13:58:00Z
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2023-07-11T16:13:06
Sponsored by Agilent
2024-03-08T10:00:25
Sponsored by Molecular Devices
2024-02-02T15:48:26
Sponsored by Bio-Techne
2025-05-08T10:38:52
Sponsored by Takara Bio USA
2024-05-07T13:11:19
Sponsored by BellBrook Labs
Site powered by Webvision Cloud